
Results
178
Companies which are potentially undervalued and in an acceptable financial position.
178 companies
High Tide
Market Cap: CA$287.3m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.25
7D
2.4%
1Y
-3.6%
Trulieve Cannabis
Market Cap: US$1.8b
Operates as a cannabis retailer in the United States.
TRLV
US$9.11
7D
7.9%
1Y
1.2%
Oxford Biomedica
Market Cap: UK£596.1m
A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.
OXB
UK£4.93
7D
-14.2%
1Y
10.9%
Hypera
Market Cap: R$15.2b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$21.57
7D
1.1%
1Y
-6.2%
CorMedix
Market Cap: US$572.7m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$7.10
7D
-4.2%
1Y
-41.2%
Innovent Biologics
Market Cap: HK$166.3b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.
1801
HK$95.15
7D
4.6%
1Y
-0.9%
UCB
Market Cap: €42.3b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€221.80
7D
-3.2%
1Y
16.6%
Green Thumb Industries
Market Cap: CA$2.2b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$9.97
7D
7.1%
1Y
-18.3%
Elanco Animal Health
Market Cap: US$11.4b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$22.13
7D
-15.6%
1Y
24.3%
Kuros Biosciences
Market Cap: CHF 912.4m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 23.00
7D
-1.7%
1Y
-13.5%
Yunnan Baiyao GroupLtd
Market Cap: CN¥90.2b
Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.
000538
CN¥50.46
7D
-0.5%
1Y
-9.7%
Hugel
Market Cap: ₩2.9t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩262,500.00
7D
-5.9%
1Y
-17.2%
Virbac
Market Cap: €2.8b
Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific.
VIRP
€333.50
7D
-1.5%
1Y
1.2%
Bavarian Nordic
Market Cap: DKK 13.8b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 180.70
7D
0.8%
1Y
-24.4%
Diaceutics
Market Cap: UK£120.1m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.42
7D
-2.4%
1Y
2.9%
Prestige Consumer Healthcare
Market Cap: US$2.5b
Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
PBH
US$52.27
7D
-1.3%
1Y
-21.3%
Dong-E-E-Jiao
Market Cap: CN¥33.8b
Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.
000423
CN¥52.68
7D
-2.2%
1Y
5.0%
Cresco Labs
Market Cap: CA$493.2m
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.
CL
CA$1.06
7D
17.8%
1Y
-29.3%
Decibel Cannabis
Market Cap: CA$63.5m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.12
7D
9.5%
1Y
-8.0%
Journey Medical
Market Cap: US$174.0m
A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
DERM
US$6.43
7D
0.5%
1Y
-11.3%
Fennec Pharmaceuticals
Market Cap: US$447.7m
Operates as a commercial stage biopharmaceutical company in the United States.
FENC
US$11.83
7D
12.5%
1Y
29.9%
Duopharma Biotech Berhad
Market Cap: RM 1.2b
Researches, develops, manufactures, markets, sells, imports, and distributes pharmaceutical products and medicines in Malaysia and internationally.
DPHARMA
RM 1.22
7D
0.8%
1Y
-6.2%
Dong-A ST
Market Cap: ₩375.9b
Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.
A170900
₩38,150.00
7D
0.8%
1Y
-13.0%
Amoy Diagnostics
Market Cap: CN¥7.2b
Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.
300685
CN¥19.75
7D
13.1%
1Y
-16.0%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.0b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€57.80
7D
-1.4%
1Y
3.3%
Dermapharm Holding
Market Cap: €2.0b
Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.
DMP
€40.05
7D
-2.7%
1Y
23.4%
Perrigo
Market Cap: US$1.8b
Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
PRGO
US$12.69
7D
-4.4%
1Y
-46.4%
Daewoong Pharmaceutical
Market Cap: ₩1.4t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩124,000.00
7D
-3.1%
1Y
-7.5%
United Laboratories International Holdings
Market Cap: HK$17.8b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$8.95
7D
-0.3%
1Y
-42.6%
China Resources Pharmaceutical Group
Market Cap: HK$30.8b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.89
7D
2.4%
1Y
-7.0%
Protara Therapeutics
Market Cap: US$231.1m
A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.
TARA
US$3.89
7D
-2.8%
1Y
19.3%
Curaleaf Holdings
Market Cap: CA$3.7b
Engages in the retail and wholesale of cannabis products in the United States and internationally.
CURA
CA$13.80
7D
17.8%
1Y
8.7%
Verastem
Market Cap: US$638.5m
A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.
VSTM
US$6.95
7D
18.4%
1Y
-13.3%
Cellectis
Market Cap: €193.4m
A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.
ALCLS
€2.66
7D
7.1%
1Y
7.5%
Vanda Pharmaceuticals
Market Cap: US$298.1m
A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.
VNDA
US$5.19
7D
2.0%
1Y
19.0%
H. Lundbeck
Market Cap: DKK 40.1b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 41.68
7D
0.4%
1Y
17.1%